SEC Form 4 · accession 0001615774-17-003801
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Pappajohn
Director · 10% Owner
Period of report
Jul 21, 2017
Accepted (ET)
Jul 25, 2017 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 21, 2017 | P | 5,000 | $4.30 | A | 521,290 | D | |
| Common Stock | Jul 21, 2017 | P | 5,000 | $4.1986 | A | 526,290 | D |
Table II — derivative securities
No Table II lines on this filing.